Legal Opinion
Schering Corp. v. Amgen, Inc.
District Court, D. Delaware
Decided February 3, 1999No. Civ.A. 96-587 MMSPublishedCited by 3 opinions
1Opinion of the Court
OPINION
SCHWARTZ, Senior District Judge.
Sehering Corporation and Biogen, Inc. (collectively “Sehering”) initially filed a patent infringement suit against Amgen, Inc. (“Amgen”) alleging infringement of its U.S. Patent No. 4,530,901 entitled “Recombinant DNA Molecules and Their Use in Producing Human Interferon-Like Polypeptides” (“ ’901 Patent”). After a hearing pursuant to Markman v. Westview Instruments, Inc., 517 U.S. 370, 116 S.Ct. 1384, 134 L.Ed.2d 577 (1996), the Court issued an Opinion and Order construing the claims of Schering’s ’901 patent. Sehering Corp. v. Amgen, Inc., 18 F.Supp.2d…
2Cases cited9 opinions
- MARKMAN Et Al. v. WESTVIEW INSTRUMENTS, INC., Et Al.Supreme Court of the United States · 1996
- Vitronics Corporation v. Conceptronic, Inc.Court of Appeals for the Federal Circuit · 1996
- Cybor Corporation v. Fas Technologies, Inc., and Fastar Ltd., Defendants-CrossCourt of Appeals for the Federal Circuit · 1998
- York Products, Inc. v. Central Tractor Farm & Family Center and Custom Form Manufacturing, Inc.Court of Appeals for the Federal Circuit · 1996
- Phonometrics, Inc. v. Northern Telecom Inc., and United Telephone Company of Florida, and Sprint CorporationCourt of Appeals for the Federal Circuit · 1998
4 more not listed; retrieve them via the Exa API.
3Cited by3 opinions
- Schering Corporation and Biogen, Inc. v. Amgen Inc.Court of Appeals for the Federal Circuit · 2000
- Schering Corp. v. Amgen, Inc.District Court, D. Delaware · 2001
- Wi-Lan Inc. v. Sharp Electronics CorporationDistrict Court, D. Delaware · 2019